| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Cenovus's prior NCIB for the purchase of up to 127,489,549 common shares is set to expire on November 10, 2025. As at October 31, 2025, Cenovus had repurchased an aggregate of 82,563,942 common shares at a weighted-average price of $21.58 per common share, excluding brokerage fees and share buyback taxes, under its prior NCIB.
Posted In: CVE